Latest Episodes
15
Clinical Trial Site Burden: Why One Study Can Mean Up to 15 Systems
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Kees van Ooik, Vice President of...
14
The "Frankenstein Instrument" Problem Why Some PRO Measures Don't Fit Today's Patients
Are the COA Instruments we've relied on for decades still measuring what matters to patients today? In this episode, Mark Wade sits down with...
12
Why eConsent Still Isn’t Standard in Clinical Trials—and What Could Change That
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow,...
14
Nothing Remains the Same: Why Measures Have to Evolve
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician...
11
The Missing Link: Why Study Design Makes or Breaks a Clinical Trial
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant...
3
Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy...